Welcome to the Coastal West Sussex Local Health Economy Formulary
August 2017 - Hydroxychloroquine recoding:
The recoding of hydroxychloroquine on our local formulary from amber to blue, was agreed at the July APC meeting. Therefore, shared care agreements are no longer required for this medicine.
August 2017 - Shortage Of Adult Hepatitis B Vaccine
There is a global shortage of hepatitis B vaccine which is currently impacting severely on the UK supply. The situation is particularly critical during August but there is likely to still be some limitations on supply until early 2018. PHE have developed temporary recommendations to support clinicians undertaking an individual risk assessment to ensure that stock is available for those individuals at highest and most immediate risk of exposure to hepatitis B: Hepatitis B vaccine shortage news link
June 2017 – Pregabalin patent expiry – neuropathic pain:
The 2015 court ruling to only prescribe pregabalin by brand when treating neuropathic pain is to be withdrawn following the patent for neuropathic pain expiring on 17th July 2017. Therefore pregabalin can now be prescribed generically for any indication. Click on the following link for further information: Pregabalin guidance
May 2017 -
Emollient savings by switching to alternative brands:
Epimax cream is a comparable product to Diprobase cream offering cost savings of 61% against Diprobase.
Isomol gel is a comparable product to Doublebase gel offering cost savings of 50% against Doublebase.
When initiating please consider the most cost effective product to meet your patients need and review existing repeat issues.
April 2017 -
Patient Safety Alert – the risks to the unborn child in women taking valproate during pregnancy:
The MHRA and NHS Improvement issued a Patient Safety Alert to highlight the risks in pregnant women taking valproate to the unborn child and details the actions NHS organisations should take in order to minimise those risks.
Go to the link below to see the full Patient Safety Alert: Resources to support safe use of valproate
March 2017 - The new diabetes pathway has been agreed: It is available to view on our formulary or by using the following link –
Adult type1 diabetic pathway
>>> more news
ABOUT THE COASTAL WEST SUSSEX LOCAL HEALTH ECONOMY FORMULARY
The Coastal West Sussex local health economy formulary is the output of processes to support the managed introduction, utilisation or withdrawal of healthcare treatments in Coastal West Sussex. It is managed through the Coastal West Sussex Area Prescribing Committee and applies to all prescribers across the local health economy including Coastal West Sussex Clinical Commissioning Group, Western Sussex Hospitals NHS Foundation Trust, Sussex Partnership NHS Foundation Trust and Sussex Community NHS Trust.
The formulary is now up to date with respect to all the traffic light document information as well as the following currently ratified full BNF therapeutic chapters:
-Musculoskeletal and joint diseases
-Low Molecular Weight Heparins
-Ear, nose, and oropharynx
The following sections have been ratified by CWS APC but are only available as standalone documents under the useful links (supporting formulary documents) currently:
-Oral Nutrional Supplements
All NICE positively appraised medicines are automatically included within the formulary (where clinically appropriate) and these can be accessed via the NICE technology appraisal adherence checklist link above. These medicines are available for clinicians to prescribe, should they choose to, in a way that supports safe and clinically appropriate practice. Prescribing responsibility is defined within the traffic light system.
The technology in a NICE technology appraisal may not be the only treatment for a particular condition. If a NICE technology appraisal recommends use of a technology, it is as an option for the treatment of a disease or condition. This means that the technology should be available for a patient who meets the clinical criteria set out in the guidance, subject to the clinical judgement of the treating clinician. The NHS must provide funding and resources when the clinician concludes and the patient agrees that the recommended technology is the most appropriate to use, based on a discussion of all available treatments
The Medicines Management team are always happy to receive any feedback on the formulary. Please use the feedback button at the top of the page if you wish to contact us in relation to the formulary.
Every care has been taken in the compilation and publication of the content on our website. However, Coastal West Sussex Area Prescribing Committee (and its consituent NHS members) will not be held responsible for any loss, damage or inconvenience caused as a result of any inaccuracy or error within these pages.
MEMBERS OF THE PUBLIC
Please note that all material in this site is aimed at healthcare professionals. Members of the public seeking advice on any medicine-related matters are encouraged to contact NHS 111 or speak with their GP, pharmacist or nurse.
Links are provided for information and convenience only. We cannot accept responsibility for the sites linked to, or the information found there. A link does not imply an endorsement of a site; likewise, not linking to a particular site does not imply lack of endorsement. Links to NHS member organisational policies or guidelines may not be accessible from all locations
We cannot accept any responsibility for any loss, disruption or damage to your data or your computer system that may occur while using material derived from this website.